Literature DB >> 18620939

Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty.

Stefania Mariani, Fiorina Giona, Sabrina Basciani, Marina Brama, Lucio Gnessi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620939     DOI: 10.1016/S0140-6736(08)61023-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

Review 1.  Effects of chemotherapy and radiotherapy on spermatogenesis in humans.

Authors:  Marvin L Meistrich
Journal:  Fertil Steril       Date:  2013-09-04       Impact factor: 7.329

2.  Longitudinal growth retardation in a prepuberal girl with chronic myeloid leukemia on long-term treatment with imatinib.

Authors:  Hansjoerg Schmid; Bernadette A S Jaeger; Judith Lohse; Meinolf Suttorp
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

Review 3.  Male Fertility Preservation.

Authors:  J Abram McBride; Larry I Lipshultz
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

4.  Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty.

Authors:  Fiorina Giona; Stefania Mariani; Lucio Gnessi; Maria Luisa Moleti; Massimiliano Rea; Annalisa De Vellis; Deborah Marzella; Anna Maria Testi; Robin Foà
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

5.  Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.

Authors:  Nobuko Hijiya; Kirk R Schultz; Markus Metzler; Frederic Millot; Meinolf Suttorp
Journal:  Blood       Date:  2015-10-28       Impact factor: 22.113

6.  How I treat childhood CML.

Authors:  Jeffrey R Andolina; Steven M Neudorf; Seth J Corey
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

Review 7.  Management of chronic myeloid leukemia in childhood.

Authors:  Meinolf Suttorp; Louise Eckardt; Josephine Tabea Tauer; Frederic Millot
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

Review 8.  New Agents, Emerging Late Effects, and the Development of Precision Survivorship.

Authors:  Eric J Chow; Zoltan Antal; Louis S Constine; Rebecca Gardner; W Hamish Wallace; Brent R Weil; Jennifer M Yeh; Elizabeth Fox
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

Review 9.  Endocrine side effects of broad-acting kinase inhibitors.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

Review 10.  Clinical review: kinase inhibitors: adverse effects related to the endocrine system.

Authors:  Maya B Lodish
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.